Chronic lymphocytic leukemia (CLL) screening and abnormality detection based on multi-layer fluorescence imaging signal enhancement and compensation
- PMID: 40067425
- PMCID: PMC11897095
- DOI: 10.1007/s00432-025-06150-9
Chronic lymphocytic leukemia (CLL) screening and abnormality detection based on multi-layer fluorescence imaging signal enhancement and compensation
Abstract
Purpose: Fluorescence in situ hybridization (FISH) plays a critical role in cancer screening but faces challenges in signal clarity and manual intervention. This study aims to enhance FISH signal clarity, improve screening efficiency, and reduce false negatives through an automated image acquisition and signal enhancement framework.
Methods: An automated workflow was developed, integrating a dynamic signal enhancement method that optimizes global and local features. An improved Cycle-GAN network was introduced, incorporating residual connections and layer-wise supervision to accurately model and compensate for complex signal characteristics. Key metrics such as signal brightness, edge gradients, contrast improvement index (CII), and structural similarity index (SSIM) were used to evaluate performance.
Results: The proposed method increased weak signal brightness by 49.02%, edge gradients by 48.61%, and CII by 32.52%. The SSIM reached 0.996, indicating high fidelity to original signals.
Conclusion: Visual analysis demonstrated clearer, more continuous, and uniform fluorescence signals, effectively mitigating fragmentation and uneven distribution. These improvements reduced false negatives and enhanced genomic abnormality detection accuracy. The proposed method significantly improves FISH signal clarity and stability, providing reliable support for cancer screening, genomic abnormality detection, molecular typing, prognosis evaluation, and targeted treatment planning.
Keywords: Fluorescence in situ hybridization (FISH); feature enhancement; cyclic generative adversarial network (Cycle-GAN); cancer screening.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. Ethical approval: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Fudan University Zhongshan Hospital (protocol code: 2022–021, date of approval: 14/02/2022). Consent to participate: Patient consent was waived due to unidentifiable information.
Figures
References
-
- Agrawal D, Yadav AC, Tyagi PK (2024) Low-light and hazy image enhancement using retinex theory and wavelet transform fusion. Multimedia Tools Appl. 10.1007/s11042-024-18459-7
-
- Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj BMC, Robrecht S, Krzykalla J, Pan H, Giza A, Akylzhanova G, Holzmann K, Scheffold A, Johnston HE, Yeh RF, Klymenko T, Tausch E, Eichhorst B, Bullinger L, Fischer K, Weisser M, Robak T, Schneider C, Gribben J, Dahal LN, Carter MJ, Elemento O, Landau DA, Neuberg DS, Cragg MS, Benner A, Hallek M, Wu CJ, Döhner H, Stilgenbauer S, Mertens D (2021) Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat Commun 12:5395. 10.1038/s41467-021-25403-y - PMC - PubMed
-
- Chen Y, Lin H, Zhang W, Chen W, Zhou Z, Heidari AA, Chen H, Xu G (2024) ICycle-GAN: Improved cycle generative adversarial networks for liver medical image generation. Biomed Signal Process Control 92:106100. 10.1016/j.bspc.2024.106100
MeSH terms
LinkOut - more resources
Full Text Sources